AUROPHARMANSEAUROBINDO PHARMA LTD· PharmaceuticalsMediumNeutral
Announced Wed, 5 Aug · 20:12 IST

Internal merger of two stepdown subsidiaries into Eugia Pharma

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹1615.00
prior close
₹1625.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-1.2-1.0-2.1+2.7+2.0+2.4+3.0+3.0+0.8+0.5+2.7
Up moveDown movePending
AI summary

Aurobindo Pharma's board has approved merging two wholly owned stepdown subsidiaries, Eugia Steriles and Eugia SEZ, into Eugia Pharma Specialities, another wholly owned subsidiary. All three make injectable pharma products. FY26 turnovers: Eugia Pharma at about 27,259 million rupees, Eugia SEZ at about 4,874 million rupees, Eugia Steriles at about 63 million rupees. No cash consideration and no change in Aurobindo's shareholding. A Scheme of Amalgamation will be filed with the Hyderabad NCLT.

Likely market impact

Internal restructuring only. No impact on shareholders, shares, or stock price. Expected to cut overheads and simplify the group.